316
News
10th May 2021

An international pandemic treaty must centre on human rights

Sara Davis and Global Health Centre
3
News
22nd May 2021

New Resource on COVID-19 Vaccine Manufacturing

Global Health Centre
3
Events
24–28 June 2019

Geneva Drug Policy Week

Global Health Centre
317
Events
28 November, 2019

Public funding of biomedical R&D: what role for public investment funds and financial markets?

Maison de la paix
Global Health Centre
3
Events
28 April, 2020

Economic Contagion: COVID-19 at the Intersection of Health, Finance and Trade

Maison de la Paix
Global Health Centre
316
News
19th November 2020

Biological Threats and Biosecurity Infrastructures

Centre on Conflict, Development & Peacebuilding
3
Publications
Policy, 2020

The vaccine race will public health prevail over geopolitics?

Suerie Moon
35
Events
25 May, 2021

Shifting the paradigm for gender equity in health innovation: transforming research and development to better meet women’s needs

Global Health Centre
3
News
22nd November 2019

Challenges to treating HIV-positive pregnant and lactating women in Malawi, and how to address them

Claire Somerville
3
Events
23 June, 2023

UN Human Rights Council Side Event: Digital Innovation, New Technologies and The Right to Health

Maison de la Paix - Online
Global Health Centre and Sara Davis
3
Events
7 December, 2022

The changing American drug policy landscape

Online
Centre on Conflict, Development & Peacebuilding
Events
20 May, 2022

International Sharing of Data & Samples; Development, Production and Access to Vaccines

Suerie Moon and Global Health Centre
Close

Goal 3 seeks to “ensure health and well-being for all, at every stage of life. The Goal addresses all major health priorities, including reproductive, maternal and child health; communicable, non-communicable and environmental diseases; universal health coverage; and access for all to safe, effective, quality and affordable medicines and vaccines. It also calls for more research and development, increased health financing, and strengthened capacity of all countries in health risk reduction and management” as the UN Sustainable Development Knowledge Platform highlights. Read more about Goal 3.

Close
Target 3.1

By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births

Target 3.2

By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births

Target 3.3

By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases

Target 3.4

By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being

Target 3.5

Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol

Target 3.6

By 2020, halve the number of global deaths and injuries from road traffic accidents

Target 3.7

By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes

Target 3.8

Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all

Target 3.9

By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination

Target 3.a

Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate

Target 3.b

Support the research and development of vaccines and medicines for the communicable and noncommunicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all

Target 3.c

Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States

Target 3.d

Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks